These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9422067)

  • 1. [New combination therapy with FTM [5-FU, pirarubicin (THP) and MMC] for treatment of inoperable advanced gastric cancer].
    Sakai Y; Miyasaka Y; Yo S; Nagayama K; Fukasaku T; Kusano F; Sakuma I; Maekawa N; Sazaki N; Tazawa J
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2233-8. PubMed ID: 9422067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)].
    Sakai Y; Kusano F; Yamamoto C; Maekawa N; Sasaki N; Tajiri K; Tazawa J
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1271-4. PubMed ID: 8031171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of recurrent gastric cancer for which combination chemotherapy with pirarubicin, cis-platinum and 5-fluorouracil were markedly effective].
    Katsumata K; Yamamoto K; Ashizawa T; Sumi T; Yamashita S; Nagashima K; Murohashi T; Majima T; Mori M; Takahashi S; Koyanagi Y
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):113-6. PubMed ID: 10660742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
    Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
    Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of nonresectable scirrhous type gastric cancer successfully treated by low-dose cisplatin (CDDP), 5-fluorouracil (5-FU) and pirarubicin (THP)].
    Gochi A; Murashima N; Gotoh K; Matsuno T; Matsuoka J; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):905-8. PubMed ID: 10897219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Oyama R; Ogata Y
    Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New interesting chemotherapeutic regimens in advanced gastric cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1991 May; 18(6):945-51. PubMed ID: 1709348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term arterial infusion chemotherapy in advanced and recurrent gastric cancer patients at home and an interesting autopsy case].
    Sato M; Terashima M; Takagane A; Saito K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1793-8. PubMed ID: 2389967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A phase I study of combination chemotherapy using TS-1 and pirarubicin (THP) for advanced gastric cancer].
    Yamamura Y; Kodera Y; Tanemura H; Oshita H; Miyashita K; Fujimura T;
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):361-5. PubMed ID: 15045941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].
    Yamamura Y; Kodera Y; Kito T
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
    Suda K; Kano Y; Inada T; Ogata Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.